Home › NDC Lookup › Ingredients › Bismuth Subsalicylate › 00904-7205-46
⚪image loading
(from DailyMed)

Major Bismuth Subsalicylate 262 mg Tablet, Chewable — NDC 0904-7205-46 (Billing 00904-7205-46)

by Major Pharmaceuticals · 5 BLISTER PACK in 1 BOX / 6 TABLET, CHEWABLE in 1 BLISTER PACK

This is a package of Major Bismuth Subsalicylate 262 mg Tablet, Chewable from Major Pharmaceuticals, marketed since Oct 2021 and currently FDA-listed; retail pharmacies pay about $0.0817 per unit (NADAC). It is this product's only package size.

NDC 00904-7205-46
🏷️ FDA NDC (as labeled) 0904-7205-46 billing pads the labeler segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 0904-7205-46 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
0904 labeler · 7205 product · 46 package
Package marketed since
Oct 11, 2021
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 0904720546 2
Medicaid fills, this package
27,906 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0904-7205-46
Product NDC 0904-7205
11-digit billing NDC 00904720546
NCPDP billing unit EA — each (per item)
RxCUI 308761
UNII 62TEY51RR1
Application # M008
SPL Set ID 2a7c9cc1-206e-4018-b89d-7b634df43df6
Established class (EPC) Bismuth
Chemical class Bismuth
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2021-10-11
Route ORAL
Dosage form TABLET, CHEWABLE
Substance BISMUTH SUBSALICYLATE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 47300010000507
GPI class Bismuth Subsalicylate
GCN Seq No 002860
GCN 08420
HICL code 001246
Ingredient (HICL) Bismuth Subsalicylate
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D6
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Colon
HIC3 code D6D
Therapeutic class — specific (HIC3) Antidiarrheals
AHFS code 56:04.00.00
AHFS class Antacids And Adsorbents
FDB label name BISMUTH 262 MG TABLET CHEW
FDB brand name Bismuth
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 002860
  • GCN: 08420
  • GPI-14 (Medi-Span): 47300010000507
  • HICL (First Databank): 001246
  • AHFS class code: 56:04.00.00
  • RxCUI (RxNorm): 308761
Why two NDCs? The FDA registers this code as 0904-7205-46 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00904-7205-46. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Bismuth class.

Pharmacologic class Bismuth
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name BISMUTH 262 MG TABLET CHEW Ingredient Bismuth Subsalicylate
📗 Our plain-language guide HelloPharmacist
  • It relieves diarrhea, including traveler's diarrhea. It also helps with upset stomach after overindulging in food and drink, such as heartburn, indigestion, nausea, gas, belching a...
  • Use it only until the diarrhea stops, and no more than 2 days. If you're not better by then, or you get worse sooner, stop and see a doctor. Drink plenty of clear fluids while you...
  • That's a known, temporary and harmless effect of this medicine. But black stool can also signal bleeding, so do not use it if you already have bloody or black stool.
  • Children under 12 should be checked by a doctor first. Children and teens who have or are recovering from chicken pox or flu-like symptoms should not use it because of Reye's syndr...
📖 Read our full Bismuth Subsalicylate guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.082 $2.45 / 30 tablets
Medicaid paysCMS SDUD · 12 mo $0.1640 $4.92 / 30 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Jan 2022 Aug 2022 Jan 2026 Sep 2026 $0.089 $0.075
▼ Down 6% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00904-7205-46 You're viewing this Main listing 5 BLISTER PACK in 1 BOX / 6 TABLET, CHEWABLE in 1 BLISTER PACK 2021-10-11 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Major Bismuth Subsalicylate 262 mgthis 00904-7205-46 Major 6 tablets $0.082 — Availability likely —
GNP Pink Bismuth 262 mg 46122-0701-65 Amerisource 6 tablets $0.082 — Availability likely —
McKesson Bismuth 262 mg 68599-4744-07 McKesson 2 tablets $0.082 — Availability likely —
Foster and Thrive Stomach Relief 262 mg 70677-1080-01 Strategic 6 tablets $0.082 — Availability likely —
Stomach Relief 262 mg 83324-0130-30 Chain 30 tablets $0.082 — Availability likely —
Stomach Relief 262 mg 70000-0591-01 CARDINAL 6 tablets $0.083 — Availability likely +1%
Walgreen Stomach Relief 262 mg 00363-1423-30 WALGREENS 6 tablets — — FDA listed —
Walgreen 262 mg 00363-9124-30 WALGREEN 30 tablets — — FDA listed —
Walgreens Bismuth Stomach Relief 262 mg 00363-9954-24 Walgreens 24 tablets — — FDA listed —
5 Symptom Digestive Relief 262 mg 11673-0723-48 TARGET 6 tablets — — FDA listed —
Rite Aid Stomach Relief Original Flavor 262 mg 11822-2430-00 RITE 6 tablets — — FDA listed —
Rite Aid Stomach Relief 262 mg 11822-4320-00 RITE 6 tablets — — FDA listed —
Pepto Relief 262 mg 17714-0045-30 Advance 30 tablets — — FDA listed —
Stomach Relief 262 mg 21130-0241-30 SAFEWAY 6 tablets — — FDA listed —
Kroger Stomach Relief 262 mg 30142-0324-30 KROGER 30 tablets — — FDA listed —
Pepto Bismol Chews 262 mg 37000-0996-24 The 24 tablets — — FDA listed —
HEB Stomach Relief Cherry 262 mg 37808-0587-77 H 6 tablets — — FDA listed —
HEB Stomach Relief 262 mg 37808-0937-77 H 6 tablets — — FDA listed —
Equaline Stomach Relief 262 mg 41163-0058-49 UNITED 6 tablets — — FDA listed —
meijer stomach relief 262 mg 41250-0878-30 Meijer 30 tablets — — FDA listed —
Chewable Stomach Relief 262 mg 41415-0124-30 PUBLIX 6 tablets — — FDA listed —
Bismuth Subsalicylate Pink Bismuth 262 mg 42507-0267-77 Hyvee 6 tablets — — FDA listed —
First Aid Direct Peptum Tabs 262 mg 42961-0109-02 Cintas 1 tablet — — FDA listed —
Medique Diotame 262 mg 47682-0210-13 Unifirst 2 tablets — — FDA listed —
Medi-First Pep-T-Med 262 mg 47682-0406-20 Unifirst 6 tablets — — FDA listed —
Pepto Bismol Chewable 5 Symptoms Relief 262 mg 50269-0555-01 JC 2 tablets — — FDA listed —
Goodsense Regular strength Stomach Relief 122 262 mg 50804-0152-49 Good 30 tablets — — FDA listed —
Stomach Relief 262 mg 51013-0321-54 PuraCap 2 tablets — — FDA listed —
CVS Stomach Relief 262 mg 51316-0124-48 CVS 48 tablets — — FDA listed —
Guardian Pink Bismuth 262 mg 53041-0021-41 Guardian 6 tablets — — FDA listed —
Guardian Pink-Bismuth Cherry 262 mg 53041-0022-49 Guardian 6 tablets — — FDA listed —
Pep Tum 262 mg 53117-0046-85 First 1 tablet — — FDA listed —
Pink Bismuth 262 mg 53943-0122-35 Discount 6 tablets — — FDA listed —
Pepto Relief 262 mg 54738-0102-30 Richmond 30 tablets — — FDA listed —
Stomach Relief 262 mg 55301-0124-30 YOUR 30 tablets — — FDA listed —
Family wellness Stomach Relief 262 mg 55319-0122-49 Family 6 tablets — — FDA listed —
Kaopectate 262 mg 55505-0206-69 Kramer 24 tablets — — FDA listed —
Regular Strength Stomach Relief 262 mg 55910-0204-30 DOLGENCORP, 6 tablets — — FDA listed —
Pepto Bismol CHEWABLES 262 mg 58933-0002-12 Procter 2 tablets — — FDA listed —
Pepto Bismol CHEWABLES 262 mg 58933-0011-02 Procter 2 tablets — — FDA listed —
Pepto Bismol CHEWABLES 525 mg/21 58933-0013-02 Procter 2 tablets — — FDA listed —
Stomach Relief 262 mg 63868-0622-30 CDMA- 30 tablets — — FDA listed —
Pepto-Bismol Chewable, TRAVEL BASIX 262 mg 66715-6423-02 Lil' 2 tablets — — FDA listed —
Pepto-Bismol Chewable, CVP HEALTH 262 mg 66715-6523-02 Lil' 2 tablets — — FDA listed —
Stomach Relief, 24-7 Life by 7-Eleven 262 mg 66715-8153-03 Lil' 2 tablets — — FDA listed —
Pepto-Bismol 262 mg 66715-9723-02 Lil' 2 tablets — — FDA listed —
WinCo FOODS Stomach Relief 262 mg 67091-0364-30 WINCO 6 tablets — — FDA listed —
Pepto Bismol 262 mg 67751-0155-01 Navajo 2 tablets — — FDA listed —
Premier Value 262 mg 68016-0124-30 CHAIN 30 tablets — — FDA listed —
Goodsense Regular strength Stomach Relief 122 262 mg 68788-4002-03 Preferred 30 tablets — — FDA listed —
Bismuth Subsalicylate 262 mg 68788-4116-03 Preferred 30 tablets — — FDA listed —
Major Bismuth Subsalicylate 262 mg 68788-8239-03 Preferred 6 tablets — — FDA listed —
Bismuth Chewable 262 mg 68998-0046-88 Marc 1 tablet — — FDA listed —
Bismuth 262 mg 69168-0046-69 Allegiant 12 tablets — — FDA listed —
Gastrobiz 262 mg 69168-0999-98 Allegiant 1 tablet — — FDA listed —
Pepto Bismol Fast Melts Fresh Berry Flavored 262 mg 69423-0831-24 The 24 tablets — — FDA listed —
Pepto Bismol Fast Melts Winter Frost Flavored 262 mg 69423-0832-24 The 24 tablets — — FDA listed —
Pepto Bismol Chews 262 mg 69423-0963-24 The 24 tablets — — FDA listed —
Bismuth Subsalicylate 262 mg 69618-0029-03 Reliable 30 tablets — — FDA listed —
CVS Health Stomach relief Cherry Flavor 262 mg 69842-0221-12 CVS 12 tablets — — FDA listed —
Stomach Relief 262 mg 69842-0394-54 CVS 2 tablets — — FDA listed —
Careone Stomach Relief 262 mg 72476-0173-72 Retail 5 tablets — — FDA listed —
Thompson Chewable Bismuth Tabs 262 mg 73408-0407-20 Thompson 6 tablets — — FDA listed —
Pept-Ache 262 mg 73598-1232-01 JHK 1 tablet — — FDA listed —
Topcare Stomach Relief Original Strength 262 mg 76162-0001-85 TopCo 30 tablets — — FDA listed —
TopCare Bismuth Stomach Relief 262 mg 76162-0406-24 TopCo 24 tablets — — FDA listed —
Meijer Bismuth Stomach Relief 262 mg 79481-0097-01 Meijer 24 tablets — — FDA listed —
Equate Stomach Relief 262 mg 79903-0089-49 Wal-Mart 6 tablets — — FDA listed —
Equate Bismuth Stomach Relief Chew 262 mg 79903-0219-24 Walmart 24 tablets — — FDA listed —
Wonderbelly Multi-Symptom 262 mg 82431-0301-04 Ginger 4 tablets — — Discontinued —
Wonderbelly Multi-Symptom 262 mg 82431-0302-04 Ginger 4 tablets — — Discontinued —
Wonderbelly Multi-Symptom 262 mg 82431-0304-04 Ginger 4 tablets — — Discontinued —
Wonderbelly Multi-Symptom 82431-0391-12 Ginger 12 tablets — — Discontinued —
Pepto Bismol 262 mg 84126-0321-70 The 70 tablets — — FDA listed —
Stomach Relief 262 mg 85828-0727-30 Grocery 6 tablets — — FDA listed —
Pepto Bismol CHEWABLES 262 mg 85237-1903-01 Select 2 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2021
On the market since
Oct 2021
📍
2026
Currently FDA-listed
5 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Bismuth Subsalicylate inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII H0G9379FGK
    Calcium carbonate is a white mineral powder used as a filler and buffering agent in medicines. It helps give tablets their bulk and size while neutralizing stomach acid in some formulations.
  • UNII 2LRS185U6K
    D&C Red No. 27 is a synthetic red colorant used in medicines and cosmetics. It gives tablets, capsules, or liquids their red or reddish color so products are visually identifiable.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 3OWL53L36A
    A natural sugar alcohol derived from seaweed or synthesized in the lab. It's used as a filler to add bulk, a sweetener in sugar-free formulas, and a disintegrant to help tablets break apart in the stomach.
  • UNII SB8ZUX40TY
    Saccharin sodium is an artificial sweetener made from saccharin salt. It's added to medicines to improve taste, especially in liquid formulations for children or bitter drugs.
  • UNII O8232NY3SJ
    A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.

6 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescalcium carbonate, D&C red 27 aluminum lake, flavor, magnesium stearate, mannitol, pregelatinized starch, saccharin sodium

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerMajor Pharmaceuticals
FDA applicationM008 (OTC MONOGRAPH DRUG)
Labeler code00904
First marketedOct 2021
Product typeHuman Otc Drug
Portfolio630 products on file

More NDCs from Major Pharmaceuticals labeler code 00904

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 Ask a Doctor or Pharmacist Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 12 words ▾

USE(S) relieves: diarrhea heartburn indigestion nausea upset stomach associated with these symptoms

⏱️ Dosage and Administration 52 words ▾

DIRECTIONS chew or dissolve in mouth adults and children 12 years and over: 2 tablets every 1/2 to 1 hour as needed do not take more than 8 doses (16 tablets) in 24 hours children under 12 years: ask a doctor drink plenty of clear fluids to help prevent dehydration caused diarrhea

⚠️ Warnings 73 words ▾

WARNINGS Reye's Syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behaviour with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's Syndrome, a rare but serious illness. Allergy alert: Contains salicylate.

Do not take if you are allergic to salicylates (including aspirin) taking other salicylate products

📦 Storage and Handling 39 words ▾

OTHER INFORMATION each tablet contains: sodium less than 1 mg salicylate 102 mg very low sodium avoid excessive heat (over 104 o F or 40 o C) TAMPER EVIDENT: Do not use if individual compartments are torn on open.

🧪 Active Ingredient 14 words ▾

ACTIVE INGREDIENT(in each tablet) Bismuth subsalicylate 262 mg (total salicylate 102 mg per tablet)

🧪 Inactive Ingredients 17 words ▾

INACTIVE INGREDIENTS calcium carbonate, D&C red 27 aluminum lake, flavor, magnesium stearate, mannitol, pregelatinized starch, saccharin sodium

🎯 Purpose 6 words ▾

PURPOSE Upset stomach reliever and anti-diarrheal

📄 Do Not Use 15 words ▾

DO NOT USE IF YOU HAVE bloody or black stool an ulcer a bleeding problem

📄 Ask a Doctor Before Use If 13 words ▾

ASK A DOCTOR BEFORE USE IF YOU HAVE fever mucus in the stool

📄 Ask a Doctor or Pharmacist Before Use If 22 words ▾

ASK A DOCTOR OR PHARMACIST BEFORE USE IF YOU ARE taking any drug for anticoagulation (thinning of the blood) diabetes gout arthritis

📄 When Using This Product 16 words ▾

WHEN USING THIS PRODUCT a temporary, but harmless darkening of the stool and/or tongue may occur

📄 Stop Use and Ask a Doctor If 24 words ▾

STOP USE AND ASK DOCTOR IF symptoms get worse ringing in the ears or loss of hearing occurs diarrhea lasts more than 2 days

🤰 If Pregnant or Breast-Feeding 10 words ▾

IF PREGNANT OR BREAST-FEEDING, ask a health professional before use.

📄 Keep Out of Reach of Children 21 words ▾

KEEP OUT OF REACH OF CHILDREN In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) immediately.

📄 Package Label / Principal Display Panel 41 words ▾

PRINCIPAL DISPLAY PANEL MAJOR NDC 0904-7205-46 *Compare to the active ingredient in Pepto-Bismol ® Bismuth Subsalicylate 262 mg Upset Stomach Reliever / Anti-diarrheal Soothing, coating action provides fast relief for heartburn, indigestion nausea, upset stomach and diarrhea 30 Chewable Tablets 3-122-30-maj-o.jpg

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
27.9K
Units reimbursed last 4 qtrs
2.1M
Gross reimbursed last 4 qtrs
$349.8K
Avg / prescription
$12.54
Avg / unit
$0.1640
Latest quarter Q1 2026
5.1KRx
Medicaid pays / ea
$0.1640
gross reimbursed
vs
NADAC / ea
$0.0817
acquisition cost
=
Spread
+$0.0823
+101% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
34% FFS 66% MCO
Fee-for-service · 9,603 Rx Managed care · 18,303 Rx
State Medicaid map
Alaska: no data reported AK Maine: 11,471 units · 822 per 100k residents ME Washington: 134,620 units · 1,723 per 100k residents WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 173,999 units · 3,033 per 100k residents MN Wisconsin: 2,167 units · 36.7 per 100k residents WI Michigan: 118,022 units · 1,176 per 100k residents MI New York: 456,317 units · 2,332 per 100k residents NY Vermont: 6,342 units · 980 per 100k residents VT New Hampshire: 1,080 units · 77.0 per 100k residents NH Oregon: 53,348 units · 1,260 per 100k residents OR Nevada: 55,026 units · 1,723 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: 121,691 units · 970 per 100k residents IL Indiana: 4,155 units · 60.6 per 100k residents IN Ohio: 115,830 units · 983 per 100k residents OH Pennsylvania: 73,659 units · 568 per 100k residents PA New Jersey: 136,860 units · 1,473 per 100k residents NJ Massachusetts: 188,899 units · 2,698 per 100k residents MA California: 2,149 units · 5.5 per 100k residents CA Utah: 1,025 units · 30.0 per 100k residents UT Colorado: no data reported CO Nebraska: 16,810 units · 850 per 100k residents NE Missouri: no data reported MO Kentucky: 69,944 units · 1,545 per 100k residents KY West Virginia: 2,570 units · 145 per 100k residents WV Virginia: 58,503 units · 671 per 100k residents VA Maryland: 44,928 units · 727 per 100k residents MD Connecticut: no data reported CT Rhode Island: 51,980 units · 4,747 per 100k residents RI Arizona: 111,965 units · 1,507 per 100k residents AZ New Mexico: 5,598 units · 265 per 100k residents NM Kansas: 1,210 units · 41.2 per 100k residents KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: 1,128 units · 21.0 per 100k residents SC Delaware: 1,068 units · 104 per 100k residents DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: 26,396 units · 239 per 100k residents GA D.C.: 14,360 units · 2,115 per 100k residents DC Hawaii: 7,680 units · 535 per 100k residents HI Texas: 62,208 units · 204 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
5.54,747
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Rhode Island 4,747 /100k
2 Minnesota 3,033 /100k
3 Massachusetts 2,698 /100k
4 New York 2,332 /100k
5 D.C. 2,115 /100k
6 Washington 1,723 /100k
7 Nevada 1,723 /100k
8 Kentucky 1,545 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Bismuth subsalicylate — the ingredient across all brands.

Top reported reactions

Chronic Kidney Disease1,418
Acute Kidney Injury822
Diarrhoea756
Renal Failure725
Nausea654
End Stage Renal Disease467
Vomiting434

Age at onset

Child6
Adolescent5
Adult367
Elderly368

Reporter sex

5,773 reports
Male · 38%
Female · 62%
Unknown · 0%

Serious outcomes

Hospitalization1,547
Disabling381
Life-threatening182
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 377 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 00904-7200-61 · Major 00904-7206-60 · Major →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.